Vilja M. Pietiainen
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.
Journal: Frontiers in immunology
Published: December 04, 2025
Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.
Journal: Molecular therapy. Oncology
Published: October 29, 2025
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
Journal: NPJ precision oncology
Published: July 23, 2025
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
Journal: NPJ precision oncology
Published: July 23, 2025
High-content Image-based Drug Testing of Patients' Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma.
Journal: Acta dermato-venereologica
Published: February 25, 2025
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.
Journal: Oncoimmunology
Published: October 01, 2024
Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma.
Journal: NPJ precision oncology
Published: August 06, 2024
Genome sequencing reveals CCDC88A variants in malformations of cortical development and immune dysfunction.
Journal: Human molecular genetics
Published: April 22, 2024
Exploiting NRF2-ARE pathway activation in papillary renal cell carcinoma.
Journal: International journal of cancer
Published: February 27, 2024
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
Journal: Antiviral research
Published: November 15, 2023
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.
Journal: Communications biology
Published: October 03, 2023
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2.
Journal: Cell reports methods
Published: December 16, 2022
Last Updated: 09/26/2026